BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-1.98%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$4.46B
AUM Growth
+$4.46B
(-14%)
Cap. Flow
-$467M
Cap. Flow
% of AUM
-10.47%
Top 10 Holdings %
Top 10 Hldgs %
48.58%
Holding
170
New
10
Increased
26
Reduced
81
Closed
22
Top Buys
| 1 |
Akero Therapeutics
AKRO
|
$50.6M |
| 2 |
AbbVie
ABBV
|
$18.9M |
| 3 |
Stryker
SYK
|
$17.3M |
| 4 |
Beam Therapeutics
BEAM
|
$17.1M |
| 5 |
Baxter International
BAX
|
$15.6M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$204M |
| 2 |
Arvinas
ARVN
|
$45.8M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$36.1M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$32.2M |
| 5 |
Tandem Diabetes Care
TNDM
|
$28.2M |
Sector Composition
| 1 | Healthcare | 99.87% |
| 2 | Technology | 0.01% |
| 3 | Communication Services | 0.01% |
| 4 | Consumer Discretionary | 0% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cencora
COR
$56.5B
| $19.8M | 0.44% | 71,360 -6,162 | -8% | -$1.71M |
|
52
Relay Therapeutics
RLAY
$619M
| $19.3M | 0.43% | 7,377,292 | – | – |
|
53
Regeneron Pharmaceuticals
REGN
$61.5B
| $18.1M | 0.41% | 28,523 -2,889 | -9% | -$1.83M |
|
54
Encompass Health
EHC
$12.3B
| $17.5M | 0.39% | 172,878 -15,644 | -8% | -$1.58M |
|
55
Elevance Health
ELV
$71.8B
| $17.4M | 0.39% | 40,058 +1,715 | +4% | +$746K |
|
56
Natera
NTRA
$23.1B
| $16M | 0.36% | 113,219 -32,457 | -22% | -$4.59M |
|
57
CareDx
CDNA
$727M
| $15.8M | 0.35% | 889,003 -485,409 | -35% | -$8.62M |
|
58
Inspire Medical Systems
INSP
$2.77B
| $15.8M | 0.35% | 99,027 -49,451 | -33% | -$7.88M |
|
59
Privia Health
PRVA
$2.83B
| $15.7M | 0.35% | 697,308 -255,856 | -27% | -$5.74M |
|
|
60
Baxter International
BAX
$12.7B
| $15.6M | 0.35% | +456,446 | New | +$15.6M |
|
61
Hologic
HOLX
$14.9B
| $15.3M | 0.34% | 247,886 | – | – |
|
62
Bruker
BRKR
$5.16B
| $14M | 0.31% | 335,288 -24,300 | -7% | -$1.01M |
|
63
Esperion Therapeutics
ESPR
$448M
| $14M | 0.31% | 9,694,064 -250,000 | -3% | -$360K |
|
64
Tenet Healthcare
THC
$16.3B
| $12.7M | 0.29% | 94,722 -15,508 | -14% | -$2.09M |
|
65
MacroGenics
MGNX
$112M
| $12.6M | 0.28% | 9,929,963 | – | – |
|
66
SI-BONE Inc
SIBN
$719M
| $12.2M | 0.27% | 872,991 -7,988 | -0.9% | -$112K |
|
67
Transmedics
TMDX
$3.92B
| $11.7M | 0.26% | 173,710 -19,008 | -10% | -$1.28M |
|
68
Masimo
MASI
$7.59B
| $11.6M | 0.26% | 69,808 +45,642 | +189% | +$7.6M |
|
69
NeoGenomics
NEO
$1.13B
| $11.5M | 0.26% | 1,216,756 +160,960 | +15% | +$1.53M |
|
70
Insmed
INSM
$28.8B
| $11.5M | 0.26% | 150,550 -107,933 | -42% | -$8.23M |
|
71
Axsome Therapeutics
AXSM
$6.05B
| $11.2M | 0.25% | 96,407 -22,523 | -19% | -$2.63M |
|
72
Johnson & Johnson
JNJ
$427B
| $11.1M | 0.25% | 67,009 +12,452 | +23% | +$2.07M |
|
73
IQVIA
IQV
$32.4B
| $10.8M | 0.24% | 61,068 +16,235 | +36% | +$2.86M |
|
74
Annexon
ANNX
$226M
| $9.95M | 0.22% | 5,157,290 | – | – |
|
|
ONC
75
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $9.62M | 0.22% | 35,329 +1,100 | +3% | +$299K |
|